Project Grant R35GM156452
Award Date
5/1/25
Completion Date
2/28/30
Dollars Obligated
$502K
Federal Agency
National Institute of General Medical Sciences
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
This federal Project Grant award, totaling $147,656.00, was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The award, effective June 6, 2025 through November 30, 2026, will support spectroscopic characterization of enzymatic intermediates with iron-sulfur (Fe-S) clusters. The project will utilize advanced electron paramagnetic resonance (EPR) and parahydrogen induced polarization (PHIP) nuclear...
This Project Grant award, totaling $647,301, was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859). The funding will support Massachusetts Institute of Technology (MIT) in advancing the understanding of iron-sulfur (Fe-S) enzymes, which catalyze important biological transformations relevant to human health and disease. The key objectives of this 5-year project are to: 1) Develop synthetic models of...
This federal Project Grant award, provided by the National Institute of General Medical Sciences (NIGMS) under CFDA program 93.859 Biomedical Research and Research Training, aims to build a better understanding of how viral pathogens hijack cellular DNA replication and repair machinery. The total award is $375,430 and runs from September 10, 2024 to July 31, 2029. The research program seeks to develop novel tools and methodologies to interrogate how viruses usurp, modify, and leverage host DNA...
This $584,420 federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports spatiotemporal mapping and engineering research on the "dark proteome" - intrinsically disordered proteins and their functions. The award, which runs from April 1, 2025 to January 31, 2030, enables researchers at the Albert Einstein College of Medicine to investigate the role of protein disorder in nuclear...
This Project Grant award, with Federal Grant Award ID K99GM155323, was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859). The $125,000 award, effective from September 1, 2024 to August 31, 2026, will support the development of a research program at the University of Utah focused on using structural homology to uncover and study independently evolved antiviral effector proteins in understudied,...
This federal Project Grant award, valued at $368,110.00 and granted by the National Institutes of Health (NIH) under the Biomedical Research and Research Training Program (CFDA 93.859), supports research into the biomimetic chemistry of mononuclear iron and copper-based oxygenase enzymes. The research aims to develop peptide-based synthetic frameworks that can stabilize and characterize the fleeting high-valent reaction intermediates involved in these enzymes' mechanisms. This will provide...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training Program (CFDA 93.859), provides $1,139,263 in funding to Purdue University to conduct research aimed at deciphering the structures and mechanisms of metalloproteins involved in human iron homeostasis. The key research objectives are: 1) elucidating iron transport through the membrane via the ferroportin and ceruloplasmin system, 2) probing the...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), supports the development of engineered enzymes that can be activated to perform targeted modifications of cellular proteins. The $1,602,000 award to the Dana-Farber Cancer Institute, Inc. (DFCI) will fund research to design and apply novel autoinhibited enzymes that can toggle between inactive and active conformations in response...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $243,713 to comprehensively investigate the interdependence of mutations in the SARS-CoV-2 Mpro protein that disrupt drug binding and those that increase enzyme activity. The two-year project aims to quantify how combinations of these mutations impact Mpro activity and drug disruption, as well as perform an unbiased...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $350,487 to the University of Illinois to conduct research on uncovering novel heme chemistry in microbial systems. The research aims to establish how divergent bacterial diheme proteins stabilize high-valent bis-FeIV states and utilize this intermediate to accomplish site-specific substrate oxidation, addressing...